Type 2 Diabetes Management: Advances in Pharmacological and Non-Pharmacological Approaches
Keywords:
Type 2 diabetes, pharmacological treatment, non-pharmacological interventions, insulin resistance, precision medicine, SGLT2 inhibitors, GLP-1 receptor agonists, lifestyle modifications, digital health, diabetes managementAbstract
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance and hyperglycemia, posing significant public health challenges worldwide. Effective management of T2DM requires a comprehensive approach, integrating pharmacological interventions with lifestyle modifications and emerging non-pharmacological strategies. This study explores recent advancements in both domains, highlighting their impact on glycemic control, disease progression, and patient outcomes. Pharmacological treatments, including metformin, sodium-glucose co-transporter-2 (SGLT2) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and dipeptidyl peptidase-4 (DPP-4) inhibitors, have demonstrated efficacy in improving insulin sensitivity and reducing cardiovascular risks. Additionally, the emergence of precision medicine in diabetes care has enabled personalized therapeutic strategies tailored to genetic and metabolic profiles.
Beyond pharmacological approaches, non-pharmacological interventions play a crucial role in diabetes management. Dietary modifications, such as low-carbohydrate and Mediterranean diets, have shown significant benefits in glycemic regulation. Physical activity, including aerobic and resistance training, enhances insulin sensitivity and aids in weight management. Digital health technologies, including continuous glucose monitoring (CGM) and artificial intelligence-driven decision support systems, have transformed diabetes self-management by providing real-time data analytics. Furthermore, behavioral interventions, psychological support, and community-based programs contribute to long-term adherence and improved quality of life for individuals with T2DM. This study underscores the importance of an integrated, patient-centered approach to diabetes care, combining pharmacological advancements with innovative non-pharmacological strategies. Future research should focus on optimizing these approaches to achieve personalized and sustainable diabetes management.